Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Biogen, Eisai kick off rolling FDA submission for subQ Leqembi
After an FDA delay, Eisai and Biogen’s effort to deploy a more convenient version of their Alzheimer’s drug Leqembi appears to be back on track.
Fraiser Kansteiner
May 14, 2024 7:51pm
Ascendis must wait 3 more months for FDA verdict on TransCon PTH
May 14, 2024 5:36pm
Sponsored
How Pharma Can Harness Education to Transform the Health Journey
May 13, 2024 8:00am
Bayer de-emphasizes the impact of Roche's Vabysmo on Eylea sales
May 14, 2024 11:46am
Sponsored
Understanding how to energize, extend and capitalize the lifespan of mature drugs
May 13, 2024 8:00am
Novo bolsters star power of obesity blockbuster Wegovy
May 14, 2024 11:40am